Paclitaxel
Active Principle
Paclitaxel 6mg/ml - 30 mg/5ml
Paclitaxel 6mg/ml - 100 mg/ 16,7 ml
Paclitaxel 6 mg/ml - 300 mg/50 ml
Presentation
Concentrate for solution for infusion vial 5 ml
Concentrate for solution for infusion vial 16,7 ml
Concentrate for solution for infusion vial 50 ml
Indication
"In first-line chemotherapy of ovarian carcinoma, As part of the adjuvant treatment, Paclitaxel is indicated for the treatment of patients with breast cancer with positive lymph nodes after anthracycline and cyclophosphamide (AC) therapy. indicated for the treatment of patients with advanced stage AIDS Kaposi (KS) sarcoma for whom previous liposomal anthracycline therapy has not been effective."
Class
Pharmaceutical product